Francesco Prati1, Enrico Romagnoli2, Francesco Burzotta3, Ugo Limbruno4, Laura Gatto5, Alessio La Manna6, Francesco Versaci7, Valeria Marco2, Luca Di Vito8, Fabrizio Imola8, Giulia Paoletti2, Carlo Trani3, Corrado Tamburino6, Luigi Tavazzi9, Gary S Mintz10. 1. San Giovanni Addolorata Hospital, Rome, Italy; Centro per la Lotta contro l'Infarto-CLI Foundation, Rome, Italy. Electronic address: fprati@hsangiovanni.roma.it. 2. Centro per la Lotta contro l'Infarto-CLI Foundation, Rome, Italy. 3. Università Cattolica Del Sacro Cuore, Rome, Italy. 4. Misericordia Hospital, Grosseto, Italy. 5. San Giovanni Addolorata Hospital, Rome, Italy; Centro per la Lotta contro l'Infarto-CLI Foundation, Rome, Italy. 6. Division of Cardiology, University of Catania, Catania, Italy. 7. Ospedale Civile Ferdinando Veneziale, Isernia, Italy. 8. San Giovanni Addolorata Hospital, Rome, Italy. 9. GVM Care and Research, E.S. Health Science Foundation, Cotignola, Italy. 10. Cardiovascular Research Foundation, New York, New York.
Abstract
OBJECTIVES: The goal of this study was to assess the clinical impact of optical coherence tomography (OCT) findings during percutaneous coronary intervention (PCI). BACKGROUND: OCT provides unprecedented high-definition visualization of plaque/stent structures during PCI; however, the impact of OCT findings on outcome remains undefined. METHODS: In the context of the multicenter CLI-OPCI (Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention) registry, we retrospectively analyzed patients undergoing end-procedural OCT assessment and compared the findings with clinical outcomes. RESULTS: A total of 1,002 lesions (832 patients) were assessed. Appropriate OCT assessment was obtained in 98.2% of cases and revealed suboptimal stent implantation in 31.0% of lesions, with increased incidence in patients experiencing major adverse cardiac events (MACE) during follow-up (59.2% vs. 26.9%; p < 0.001). In particular, in-stent minimum lumen area <4.5 mm(2) (hazards ratio [HR]: 1.64; p = 0.040), dissection >200 μm at the distal stent edge (HR: 2.54; p = 0.004), and reference lumen area <4.5 mm(2) at either distal (HR: 4.65; p < 0.001) or proximal (HR: 5.73; p < 0.001) stent edges were independent predictors of MACE. Conversely, in-stent minimum lumen area/mean reference lumen area <70% (HR: 1.21; p = 0.45), stent malapposition >200 μm (HR: 1.15; p = 0.52), intrastent plaque/thrombus protrusion >500 μm (HR: 1.00; p = 0.99), and dissection >200 μm at the proximal stent edge (HR: 0.83; p = 0.65) were not associated with worse outcomes. Using multivariable Cox hazard analysis, the presence of at least 1 significant criterion for suboptimal OCT stent deployment was confirmed as an independent predictor of MACE (HR: 3.53; 95% confidence interval: 2.2 to 5.8; p < 0.001). CONCLUSIONS: Suboptimal stent deployment defined according to specific quantitative OCT criteria was associated with an increased risk of MACE during follow-up.
OBJECTIVES: The goal of this study was to assess the clinical impact of optical coherence tomography (OCT) findings during percutaneous coronary intervention (PCI). BACKGROUND: OCT provides unprecedented high-definition visualization of plaque/stent structures during PCI; however, the impact of OCT findings on outcome remains undefined. METHODS: In the context of the multicenter CLI-OPCI (Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention) registry, we retrospectively analyzed patients undergoing end-procedural OCT assessment and compared the findings with clinical outcomes. RESULTS: A total of 1,002 lesions (832 patients) were assessed. Appropriate OCT assessment was obtained in 98.2% of cases and revealed suboptimal stent implantation in 31.0% of lesions, with increased incidence in patients experiencing major adverse cardiac events (MACE) during follow-up (59.2% vs. 26.9%; p < 0.001). In particular, in-stent minimum lumen area <4.5 mm(2) (hazards ratio [HR]: 1.64; p = 0.040), dissection >200 μm at the distal stent edge (HR: 2.54; p = 0.004), and reference lumen area <4.5 mm(2) at either distal (HR: 4.65; p < 0.001) or proximal (HR: 5.73; p < 0.001) stent edges were independent predictors of MACE. Conversely, in-stent minimum lumen area/mean reference lumen area <70% (HR: 1.21; p = 0.45), stent malapposition >200 μm (HR: 1.15; p = 0.52), intrastent plaque/thrombus protrusion >500 μm (HR: 1.00; p = 0.99), and dissection >200 μm at the proximal stent edge (HR: 0.83; p = 0.65) were not associated with worse outcomes. Using multivariable Cox hazard analysis, the presence of at least 1 significant criterion for suboptimal OCT stent deployment was confirmed as an independent predictor of MACE (HR: 3.53; 95% confidence interval: 2.2 to 5.8; p < 0.001). CONCLUSIONS: Suboptimal stent deployment defined according to specific quantitative OCT criteria was associated with an increased risk of MACE during follow-up.
Authors: Tomasz Roleder; Magdalena Dobrolinska; Elzbieta Pociask; Wojciech Wanha; Grzegorz Smolka; Wojciech Walkowicz; Radoslaw Parma; Mariusz Lebek; Tomasz Bochenek; Przemysław Pietraszewski; Elvin Kedhi; Andrzej Ochala; Zbigniew Gasior; Ziad A Ali; Wojciech Wojakowski Journal: Cardiol J Date: 2018-09-24 Impact factor: 2.737
Authors: Dariusz Dudek; Waldemar Banasiak; Wojciech Braksator; Jacek Dubiel; Tomasz Grodzicki; Piotr Hoffman; Mariusz Kuśmierczyk; Grzegorz Opolski; Piotr Ponikowski; Jacek Różański; Jerzy Sadowski; Wojciech Wojakowski; Marcin Grabowski; Katarzyna Bondaryk; Jacek Walczak; Izabela Pieniążek; Maciej Grys; Anna Lesiak-Bednarek; Piotr Przygodzki Journal: Cardiol J Date: 2019-02-14 Impact factor: 2.737
Authors: Stylianos A Pyxaras; Tom Adriaenssens; Emanuele Barbato; Giovanni Jacopo Ughi; Luigi Di Serafino; Frederic De Vroey; Gabor Toth; Shengxian Tu; Johan H C Reiber; Jeroen J Bax; William Wijns Journal: Int J Cardiovasc Imaging Date: 2017-10-27 Impact factor: 2.357
Authors: Himanshu Rai; Fiona Harzer; Tatsuhiko Otsuka; Youssef S Abdelwahed; Paula Antuña; Florian Blachutzik; Tobias Koppara; Lorenz Räber; David M Leistner; Fernando Alfonso; Holger Nef; Masaru Seguchi; Alp Aytekin; Erion Xhepa; Sebastian Kufner; Salvatore Cassese; Karl-Ludwig Laugwitz; Robert A Byrne; Adnan Kastrati; Michael Joner Journal: J Am Heart Assoc Date: 2022-04-26 Impact factor: 6.106